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Abstract
Purpose of Review The purpose of this review was to eluci-
date the additional value of 3D echocardiography for the as-
sessment of mitral regurgitation (MR) compared to standard
2D echocardiography.
Recent Findings 3D echocardiography provides key informa-
tion, aetiology, degenerative mitral valve disease vs. second-
ary MR, causes and mechanism, severity by measurements of
effective regurgitant orifice area and regurgitant volume; like-
lihood of reparability and assessment of pre- and intra-mitral
valve transcatheter procedures.
Summary 3D echocardiography as a promising method for
assessment of MR is useful and crucial for research, clinical
practice and patient management in all heart valve team
members.
Keywords 3D echocardiography . Assessment . Mitral
regurgitation . Transoesophageal echocardiography .
Transcatheter procedures
Abbreviations
MR Mitral regurgitation
2D 2-Dimensional
3D 3-Dimensional
DMVD Degenerative mitral valve disease
LV Left ventricular
PISA Proximal isovelocity surface area
EROA Effective regurgitant orifice area
Introduction
Mitral regurgitation (MR) is the second most frequent heart
valve disease in developed countries. The assessment of the
aetiology, mechanism, severity and reparability is essential for
the decision-making process for transcatheter/surgical MR
treatment. Transthoracic echocardiography is recommended
as the first-line imaging modality for assessment of mitral
valve anatomy, MR severity, its haemodynamics and ventric-
ular consequences [1, 2••]. When transthoracic echocardiog-
raphy is of non-diagnostic value or whenever further diagnos-
tic refinement is required, transoesophageal echocardiography
is advocated. Although 2D echocardiography is the primary
imaging modality in both transthoracic and transoesophageal
echocardiography, this paper focuses on the additional value
of 3D echocardiography in the assessment of MR.
Aetiology
MR is classified as primary (organic) or secondary (functional)
[1]. Common causes of primary MR are degenerative mitral
valve disease, rheumatic disease and endocarditis. Degene-
rative mitral valve disease, including diffuse myxomatous de-
generation, fibroelastic degeneration, Marfan, Ehlers-Danlos
syndrome and annular calcification, is often morphologically
sub-classified as the following: (1) billowing (a part of the
mitral valve body protrudes into the left atrium but coaptation
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is preserved beyond the annular plane), (2) floppy (a morpho-
logic abnormality with thickened leaflet), (3) prolapse (a part
of coaptation line is behind the annular plane), (4) flail (a free
edge of a leaflet is completely reversed in the left atrium) [1].
The most common phenotype of mitral valve prolapse is dif-
fuse myxomatous degeneration. Mitral valve annular dilata-
tion in mitral valve prolapse is associated with the basal pre-
dominance of left ventricular (LV) dilatation and attenuated
contraction, which can be altered by surgical mitral
valvuloplasty with annulus reduction [3••]. A recent study
using real-time 3D transoesophageal echocardiography has
shown that flattening of the annular saddle shape is associated
with progressive leaflet billowing and increased frequencies of
chordal rupture in mitral valve prolapse [4].
Common causes of secondary MR are ischaemic heart dis-
ease and dilated cardiomyopathy. It results from an imbalance
between tethering forces (annular dilatation, LV dilatation,
papillary muscles displacement, LV sphericity, high left atrial
pressure) and closing forces (reduction of LV contractility,
global LV dyssynchrony, papillary muscle dyssynchrony, al-
tered mitral systolic annular contraction) [1]. 3D echocardiog-
raphy has contributed most to the understanding of the struc-
tural remodelling that accompanies secondary MR [5–7] and
has demonstrated superiority over 2D echocardiography in
measuring LV volumes, localizing and assessing the extent
of mitral valve deformation, and determining the shape of
the regurgitant orifice [8] (Fig. 1).
Mechanism
The rationale for mitral valve treatment depends on the MR
mechanism, and therefore it is essential to identify and under-
stand the pathophysiology of MR. The Carpentier’s classifi-
cation of mitral leaflet pathology is defined surgically as fol-
lows: (1) type I, normal leaflet motion (annular dilation, leaflet
perforation); (2) type II, excessive leaflet motion (leaflet pro-
lapsed, chordal rupture, chordal elongation, papillary muscle
rupture, papillary muscle elongation); (3) type III, restricted
leaflet motion (type IIIa, during diastole and systole due to
shortening of the chordae and/or leaflet thickening such as in
rheumatic MR and type IIIb, during systole such as in ischae-
mic MR).
3D dynamic imaging has demonstrated the dynamic nature
of mitral annulus physiology during the cardiac cycle. In both
healthy subjects and myxomatous valve patients, annular area
increased between early and middle or late systole. In this
period, annular area returns to diastolic area in the normal
annulus but enlarges beyond diastolic area in myxomatous
valve patients. Then, saddle-shape deepening occurs later
and is less pronounced in myxomatous valve patients com-
pared with healthy subjects [9]. Moreover, a recent study
using real-time 3D transoesophageal echocardiography has
demonstrated that the phenotypes of degenerative mitral valve
disease (fibroelastic degeneration vs. diffuse myxomatous de-
generation) display considerably different valvular pathophys-
iology [10••]. In fibroelastic degeneration, annular dynamics is
similar to that in healthy subjects (early systolic anteroposterior
contraction and saddle-shape accentuation with stable
intercommissural diameter). In diffuse myxomatous degenera-
tion, however, annular dynamics is greatly abnormal in early
systole (reduced anteroposterior contraction and saddle-shape
accentuation) and late systole (abnormal enlargement because
of marked intercommissural enlargement).
Patient-specific mitral leaflet strain analysis using 3D
transoesophageal echocardiography has reported that patients
with primary MR have higher mitral valve strain compared to
normal subjects, and that strain concentration is the highest in
the commissural zone, intermediate in the annulus and coap-
tation zones and the lowest in the central zone [11••].
Recently, the relationship between annular dilatation caused
by atrial fibrillation and MR has been also studied by 3D
transoesophageal echocardiography [12••]. Although annular
area is greater in atrial fibrillation patients both with and with-
out MR than healthy subjects, total leaflet area remains greater
in atrial fibrillation patients without MR compared to those
with MR or healthy subjects.
Secondary MR develops because of a combination of mi-
tral leaflet tethering secondary to LV dilatation/deformation
with papillary displacement/discoordination, annular dilata-
tion/dysfunction, insufficient LV-generated closing forces at-
tributable to reduction of LV contractility and global LV/
papillary muscle dyssynchrony. Tethering of the mitral leaflets
is the principal lesion of secondary MR and results in restric-
tion of systolic leaflet motion (type IIIb of Carpentier’s clas-
sification). Measures of mitral valve configuration parameters
are now readily available using 3D echocardiography, which
reduces the risk of foreshortened views and off-axis planes by
2D echo. It provides accurate evaluation of leaflets remodel-
ling and mitral annulus dimensions and dynamics. Tenting
volume shape can be reconstructed through offline analysis
from 3D-acquired data sets. Examining the tenting volume
shape makes it easy to identify the pattern of tethering (sym-
metric vs. asymmetric) on the MV leaflets, asymmetric teth-
ering exhibiting a tenting volume deformed toward the most
tethered segment of the leaflet and pointing out the part of the
leaflet that is predominantly stretched. The tenting volume,
the volume enclosed between the MV leaflets and the annular
plane in mid-systole, is closely related to MR severity and is a
reliable marker of tethering severity [13, 14].
MR Severity
2D echocardiography plays an essential role in the assess-
ment of MR severity. The criteria for grading MR with 2D
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echocardiography are described in Table 1 [15, 16•].
Qualitatively, colour flow imaging is the most common way
to assess MR severity. The density of the continuous wave
Doppler envelope of the MR jet can provide clues about MR
degree. The presence of a flow convergence at a Nyquist limit
of 50–60 cm/s should alert to the presence of significant MR.
Semiquantitatively, a vena contracta < 3 mm indicates mild
MR whereas a width ≥ 7 mm defines severe MR. Pulsed
Doppler evaluation of pulmonary venous flow pattern is also
an aid to assess MR severity. A peak E velocity > 1.5 m/s
suggests severe MR in the absence of mitral stenosis whereas
a dominant Awave basically excludes severe MR. The pulsed
Doppler mitral to aortic time velocity integral ratio (i.e. > 1.4)
can be used as an index in primary severe MR. Quantitatively,
the flow convergence method is the most recommended quan-
titative approach whenever feasible. The radius of the proxi-
mal isovelocity surface area (PISA) ismeasured at mid-systole
using the first aliasing. The PISA method is based on the
assumption of haemispheric symmetry of the velocity distri-
bution proximal to the regurgitant lesion, which may not hold
for eccentric jets, multiple jets and complex or elliptical
regurgitant orifices. In the European Society of Cardiology
(ESC)/European Association for Cardio-Thoracic Surgery
(EACTS) guidelines [15], primary MR is considered severe
if effective regurgitant orifice area (EROA) is ≥ 40 mm2 and
regurgitant volume ≥ 60 mL. In secondary MR, the thresholds
of severity are 20 mm2 and 30 mL, respectively. In the 2017
American Heart Association (AHA)/American College of
Cardiology (ACC) focused update guidelines [16•], on the
basis of the criteria used for determination of severe MR in
randomized controlled trials of surgical intervention, both pri-
mary and secondary MR are considered severe if EROA is
≥ 40 mm2, regurgitant volume ≥ 60 mL and regurgitant frac-
tion ≥ 50%. The presence of severe MR has significant hae-
modynamic effects, primarily on the LVand left atrium.When
MR is more than mild, providing the LV diameters, volumes
and ejection fraction as well as the left atrium volume and the
pulmonary arterial systolic pressure in the final echocardio-
graphic report is mandatory. 3D echo has demonstrated supe-
riority over 2D echo and similar accuracy to cardiac magnetic
resonance imaging in evaluating LV volumes and LVejection
fraction [17].
Assessment of MR using 3D echocardiography is reason-
able to provide additional information on severity, especially
inmeasurements of EROA and regurgitant volume. In patients
with primary or secondary MR, 3D EROA is well correlated
with cardiac magnetic resonance imaging regurgitant volume
[18]. 3D echocardiography overcomes the current limitations
of 2D echo by a direct measurement of vena contracta area
(direct planimetry) in the plane perpendicular to the direction
of the regurgitant jet with no geometric assumptions. 3D-
derived vena contracta area has been shown to correlate more
Fig. 1 Dynamicity of the
regurgitant orifice during systole
as depicted by 3D transthoracic
echocardiography
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closely with Doppler-derived EROA than 2D vena contracta
diameter. A vena contracta area of ≥ 0.41 cm2 seems to be
indicative of severe MR although further validation of this
cut-off is necessary given that the comparison standard in
most have been conventional 2D estimates of severity of
MR [19]. The PISA method, as assessed by 2D echocardiog-
raphy, assumes that the flow convergence area is haemis-
pherical. As demonstrated by 3D echocardiography, flow con-
vergence area is frequently haemielliptic in secondary MR
(Fig. 2) and applying PISA radius method in this case might
lead to underestimation of EROA and regurgitant volume. A
recent research demonstrated that the 3D PISA method is
more accurate than the current the 2D PISA method in these
patients [20••]. With 3D echocardiography, it is also possible
to directly measure the 3D surface of proximal isovelocity
layers without raw geometric assumptions [21]. This approach
is an accurately correlated cardiac magnetic imaging with car-
diac magnetic resonance imaging regurgitant volume in sec-
ondary MR, although further confirmation of this is required
in larger numbers and in multiple centres [18]. However, it is
not clear whether these 3D echo measurements provide incre-
mental information to standard 2D echo measures for
predicting outcome after treatment.
Reparability
In the decision-making process for transcatheter/surgical MR
treatment, a heart valve team should consider various factors
affecting the individual risk: symptoms, severity of MR, hae-
modynamic effects of MR, operative risk and feasibility of
repair. There is a heterogeneous rate of mitral valve repair
among hospitals and among surgeons [22], although mortality
and complications associated with mitral valve repair has been
reported to be lower than with mitral valve replacement.
Although 2D echo has been established as the referencemethod
formitral valve analysis, 3D transthoracic and transoesophageal
echocardiography add significant information on, especially in
patients with complex lesions. Unlike 2D techniques, which
require multiple tomographic views to examine the different
parts of the mitral valve leaflets, real-time 3D echocardiography
provides a comprehensive assessment of the mitral valve in
only one view, the “en face” view from the left atrium (sur-
geon’s view, Fig. 3) or the LV, leading to more effective com-
munication with cardiac surgeons [23]. Several studies have
demonstrated, at the time of surgery (surgical inspection), the
superiority of 3D over 2D echocardiography [24, 25]. 3D trans-
thoracic echocardiography has been shown to be feasible and
accurate in identifying the location of MV prolapse with sensi-
tivity comparable to 2D transoesophageal echocardiography
when the quality of images is sufficient [26]. Characteristics
of 2D and 3D-derived echocardiographic parameters obtainable
in MR are described in Table 2.Ta
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Isolated cleft of the anterior mitral valve leaflet is a rare but
well-known finding. During surgical inspection when the
heart is collapsed, it is sometimes difficult to identify cleft
and cleft-like indentations, especially if the scallops are dis-
eased. 2D transoesophageal echocardiography, despite
multiplane imaging, often has difficulty identifying typical
cleft and cleft-like indentations, which may be associated with
MR and failure of mitral valve repair. 3D transoesophageal
echocardiography with proper “en face” image display from
the ventricular side has high sensitivity, specificity, positive
predictive value and negative predictive value for cleft-like
indentation diagnosis [27••]. Detection of the mitral valve
dysfunction following mitral valve repair is also required.
2D and 3D transoesophageal echocardiography should be per-
formed in all cases of recurrent mitral valve dysfunction be-
cause of superior spatial resolution and anatomic detail [28•].
MR Assessment for Transcatheter Procedures
During the past few years, several percutaneous transcatheter
mitral valve repair technologies have emerged as possible
Fig. 2 Elliptical regurgitant
orifices assessed by 2D and 3D
transthoracic echocardiography
Fig. 3 Surgeon’s view of the
mitral valve P2 prolapse by 3D
transoesophageal
echocardiography
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alternatives to open surgery for high-risk patients. As new
therapeutic targets, leaflets (percutaneous leaflet plication, leaf-
let coaptation, leaflet ablation), annulus (indirect annuloplasty
through the coronary sinus or direct annuloplasty), chordae
(percutaneous chordal implantation) and LV (percutaneous
LV remodelling) are proposed and still under development
except for the leaflet approaches with the use of MitraClip
(edge-to-edge repair) [29•]. MitraClip therapy has proven suc-
cessful in reducing the severity ofMR and in improving the LV
dimension, patient’s symptoms, quality-of-life and functional
capacity [30]. Transcatheter mitral valve replacement is also
recognized as a new therapeutic procedure and may have the
potential to become an alternative to treat severe MR in pa-
tients with high surgical risk. For transcatheter mitral valve
replacement, 3D transoesophageal echocardiography is most
useful for anatomical assessment and quantification, annular
segmentation (aortic cusps, aortomitral continuity, trigone, left
atrial appendage, posterior annulus) and landing zone charac-
teristics (annular calcium, mitral valve prolapse, mitral annular
disjunction, myocardial shelf, leaflet length, directly inserting
papillary muscles), and for intraprocedural guidance by pro-
viding an en face view [31••, 32•]. For paravalvular percuta-
neous closure, 3D transoeso-phageal echocardiography can be
used intraprocedurally and also permits assessment of location
and severity of paravalvular leak.
Conclusion
3D echocardiography provides additional value for the
assessment of MR. Aetiologically, 3D echocardiography
has contributed to the understanding of the structural re-
modelling and the interrelationship between the mitral
valve and LV in both primary and secondary MR. The
assessment of the dynamic nature of mitral annulus phys-
iology and pathophysiology in MR by real-time 3D
transoesophageal echocardiography gives new insights in-
to the mechanisms of MR. From a clinical point of view,
the application of assessment of MR severity using 3D
echocardiography is still challenging as a standard meth-
od. Although there is less evidence to show the therapeutic
effect of 3D echocardiography-guided mitral valve repair, pre-
and intra-operative 3D “en face” images help heart valve team
members communicate with each other. For transcatheter mi-
tral valve procedures, 3D transoesophageal echocardiography
is essential for pre- and intra-procedural assessment such as
annular segmentation and landing zone characteristics and for
intraprocedural guidance.
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